Literature DB >> 363432

Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo).

K Kølendorf, P Aaby, S Westergaard, T Deckert.   

Abstract

The clinical characteristics of highly purified porcine NPH-insulin (Insulin Retard RI) were investigated, including absorption from the subcutaneous tissue, blood glucose-lowering effect, stability of mixtures of NPH and regular insulin and measurement of circulating porcine proinsulin and insulin antibodies in diabetes. The absorption of NPH-insulin followed first order kinetics. The half time was 6.9 +/- 2.6h, with an intraindividual coefficient of variation of 26% and an interindividual coefficient of variation of 55%. After 24 h 90% of the injected insulin had disappeared from the subcutaneous tissue. The plasma insulin concentration was maximal 4-5 h after the injection and 24 h after the injection it was not significantly higher than before the injection. The blood glucose-lowering effect was significant 2.5 h after subcutaneous injection of NPH-insulin and was maximal after 5.5 h. The blood glucose-lowering effect of a pre-prepared mixture of 70% NPH and 30% regular insulin was not significantly different from the effect of 70% NPH and 30% regular insulin injected separately, which indicates the stability of mixtures of NPH and Regular insulin. Porcine proinsulin disappeared from the serum of patients switched to treatment with highly purified porcine NPH insulin and the insulin antibody titer fell. It was concluded that insulin Retard RI has a well-defined, reproducible effect with a clinically useful time course.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363432     DOI: 10.1007/bf00607442

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  [Insulin Monotard and Insulin Lente. Comparison of absorption and clinical effects].

Authors:  O K Faber; T Lauritzen; C Binder; H T Mouridsen; A Volund
Journal:  Ugeskr Laeger       Date:  1975-10-20

Review 2.  Immunity and autoimmunity in diabetes mellitus.

Authors:  M Christy; T Deckert; J Nerup
Journal:  Clin Endocrinol Metab       Date:  1977-07

3.  Absorption of protamine-insulin in diabetic patients. I. Preparation and characterization of protamine-125I-insulin.

Authors:  B Hansen; S Linde; K Kølendorf; F Jensen
Journal:  Horm Metab Res       Date:  1979-02       Impact factor: 2.936

4.  Radioimmunoassays employing immunosorbents.

Authors:  L Wide
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1969

5.  The clinical significance of highly purified pig-insulin preparations.

Authors:  T Deckert; O O Andersen; J E Poulsen
Journal:  Diabetologia       Date:  1974-12       Impact factor: 10.122

6.  Concentration of porcine proinsulin-like material in plasma of insulin-treated diabetics in relation to purity of insulin preparations.

Authors:  P Aaby
Journal:  Horm Metab Res       Date:  1979-08       Impact factor: 2.936

7.  Effect of "fractionated" insulins on total plasma insulin binding capacity and insulin requirements in severe diabetes.

Authors:  N W Oakley
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

8.  Effects of leg exercise on insulin absorption in diabetic patients.

Authors:  V A Koivisto; P Felig
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

  8 in total
  4 in total

Review 1.  Exposing concerns about vaccination in low- and middle-income countries: a systematic review.

Authors:  Daniel Cobos Muñoz; Laura Monzón Llamas; Xavier Bosch-Capblanch
Journal:  Int J Public Health       Date:  2015-08-23       Impact factor: 3.380

2.  NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.

Authors:  S Jørgensen; A Vaag; L Langkjaer; P Hougaard; J Markussen
Journal:  BMJ       Date:  1989-08-12

3.  Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels.

Authors:  H Süsstrunk; B Morell; W H Ziegler; E R Froesch
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

4.  Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes.

Authors:  M G Gnanalingham; P Newland; C P Smith
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.